10Sep 2017

STEREOTACTIC VOLUME MODULATED ARC RADIOTHERAPY PROTOCOL FOR CANINE INTRACRANIAL MENINGIOMA.

  • La Cittadina Fondazione Studi e Ricerche Veterinarie, Romanengo (CR), Italy.
  • Azienda Socio Sanitaria Territoriale di Lodi, Lodi, Italy.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Objective: to assess High Dose Hypofractionated Volume Modulated Arc Radiotherapy (HDH-VMAT) feasibility and clinical efficacy in canine meningiomas. Design: a prospective study was conducted on thirty-three patients with a presumptive diagnosis of encephalic meningiomas assumed from Magnetic Resonance Imaging (MRI) findings. Methods: all dogs, whose neurological status was scored through the use of an innovative evaluation scale (Romanengo Veterinary Neurological Scale ? RVNS), received HDH-VMAT by a Linear Accelerator (LINAC) equipped with an external beam modulator micro-multileaf collimator and an XVI Cone Beam Computed Tomography system (CBCT). The prescribed mean dose was 33 Gy delivered in 5 fractions. The treatment feasibility was tested through planned and delivered dose agreement checks. Regular clinical examinations were performed during and after irradiation time with regard to mentation, deambulation, cranial nerve dysfunction and seizures. Serial MRI exams were done 60 days after irradiation and after 4, 6, 12, 18, 24 months. Volumetric disease reduction criteria implemented with clinical neurological systematic evaluation were adopted to assess the course and to categorize patients? response. Results: complete and partial responses were observed on the whole in 65,5% of alive patients 24 months after irradiation. Two-year overall and disease-specific survival rates were 74.3% and 97.4%, respectively, and the putative radiotoxic effects were found to be few and slight. Conclusions: HDH-VMAT is a valid therapeutic option for encephalic canine meningioma. Volumetric MRI evaluation together with the hereby proposed RVNS should be considered for the evaluation of the post-treatment response.

  1. LeCouteur RA, Withrow SJ. Tumors of the Nervous System. In: Withrow SJ, Vail DM editors. Withrow and MacEwen?s small animal clinical oncology. 4th edn. Saunders, St.Louis, 2007: 665-670.
  2. Snyder JM, Shofer FS, Van Winkle TJ, Massicotte C. Canine intracranial primary neoplasia: 173 cases (1986-2003). J Vet Intern Med. 2006 May-Jun;20(3):669-75.
  3. Motta L, Mandara MT, Skerritt GC. Canine and feline intracranial meningiomas: an updated review. Vet J. 2012;192:153-165.
  4. Sturges BK, Dickinson PJ, Bollen AW, Koblik PD, Kass PH, Kortz GD, Vernau KM, Knipe MF, Lecouteur RA, Higgins RJ. Magnetic resonance imaging and histological classification of intracranial meningiomas in 112 dogs. J Vet Intern Med. 2008 May-Jun;22(3):586-95.
  5. Bley CR, Sumova A, Roos M, et al. Irradiation of brain tumors in dogs with neurologic diseases. J Vet Intern Med. 2005;19:849-854.
  6. Polizopoulou ZS, Koutinas AF, Souftas VD, et al. Diagnostics correlation of CT-MRI and histopathology in 10 dogs with brain neoplasm. J Vet Med Series A. 2004;51:226-231.
  7. Dickinson PJ, Sturges BK, Kass PH, LeCouteur RA. Characteristics of cisternal cerebrospinal fluid associated with intracranial meningiomas in dogs: 56 cases (1985-2004). J Am Vet Med Assoc. 2006 Feb 15;228(4):564-7.
  8. Oakley RO, Patterson JS. Tumors of the Central and Peripheral Nervous System. In: Slatter D Texbook of small animal surgery. 3rd edn. Saunders, Philadelphia, 2002: 2413-2414.
  9. Turrel JM, Fike JR, LeCouteur RA, Pflugfelder CM, Borcich JK. Radiotherapy of brain tumors in dogs. J Am Vet Med Assoc. 1984 Jan 1;184(1):82-6.
  10. Evans SM, Dayrell-Hart B, Powlis W, Christy G, VanWinkle T. Radiation therapy of canine brain masses. J Vet Intern Med. 1993 Jul-Aug;7(4):216-9.
  11. Lester NV, Hopkins AL, Bova FJ, et al. Radiosurgery using a stereotactic headframe system for irradiation of brain tumors in dogs. JAVMA. 2001;219:1562-1567.
  12. Brearley MJ, Jeffrey ND, Phillips SM, et al. Hypofractionated radiation therapy of brain masses in dogs: a retrospective analysis of survival of 83 cases (1991?1996). J Vet Intern Med 1999;13:408-412.
  13. Spugnini EP, Thrall DE, Price GS, et al. Primary irradiation of canine intracranial masses. Vet Radiol Ultrasound. 2000;41:377-380.
  14. Keyerleber MA, McEntee MC, Farrelly J, Thompson MS, Scrivani PV, Dewey CW.
  15. Three-dimensional conformal radiation therapy alone or in combination with
  16. surgery for treatment of canine intracranial meningiomas. Vet Comp Oncol. 2015
  17. Dec;13(4):385-97.
  18. Axlund TW, McGlasson ML, Smith AN. Surgery alone or in combination with radiation therapy for treatment of intracranial meningiomas in dogs: 31 cases (1989?2002). J Am Vet Med Assoc 2002;221:1597-1600.
  19. Mariani CL, Schubert TA, House RA, et al. Frameless stereotactic radiosurgery for the treatment of primary intracranial tumours in dogs. Vet Comp Oncol 2013 Sep 6. doi:10.1111/vco.12056
  20. Wisner ER, Dickinson PJ, Higgins RJ. Magnetic resonance imaging features of canine intracranial neoplasia. Vet Radiol Ultrasound 2011;52:52-61.
  21. Rodenas S, Pumarola M, Gaitero L, et al. Magnetic resonance imaging findings in 40 dogs with histologically confirmed intracranial tumours. Vet J 2011;187:85-91.
  22. Wolff CA, Holmes SP, Young BD, et al. Magnetic resonance imaging for the differentiation of neoplastic, inflammatory, and cerebrovascular brain disease in dogs. J Vet Intern Med 2012;26:589-597.
  23. Starke RM, Williams BJ, Hiles C, et al. Gamma knife surgery for skull base meningiomas. J Neurosurg 2012;116:588-597.
  24. Benedict SH, Yenice KM, Followill D, et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 2010;37:4078?101.
  25. Pollock BE. Stereotactic radiosurgery of benign intracranial tumors. J Neuroncol 2009;92:337-343.
  26. Low DA, Harms WB, Mutic S, et al. A technique for the quantitative evaluation of dose distributions. Medical Phys 1998;25:656-661.
  27. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-247.
  28. Ladue T, Klein MK. Toxicity criteria of the veterinary radiation therapy oncology group. Vet Radiol Ultrasound 2001;42:475-476.
  29. McBride WH, Withers HR. Biologic basis of radiation therapy. In: Perez and Brady?s editors. Principles and practice of radiation oncology. 5th edn. Lippincott Williams & Wilkins, Philadelphia, 2008:76-108.
  30. Adamo PF, Forrest L, Dubielzig R. Canine and feline meningiomas: diagnosis, treatment and prognosis. Compend Contin Educ Pract Vet 2004;26:951-964.
  31. Minniti G, Amichetti M, Enrici RM. Radiotherapy and radiosurgery for benign skull base meningiomas. Radiat Oncol 2009;4:42.
  32. Vernimmen FJ, Slabbert JP. Assessment of the alpha/beta ratios for arteriovenous malformations, meningiomas, acoustic neuromas, and the optic chiasma. Int J Radiat Biol 2010;86:486-498.
  33. Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989;62:679-694.
  34. Pedraza Muriel V. Hypofractionation in radiotherapy. Clin Transl Oncol 2007;9:21-27.
  35. Compter I,?Zaugg K,?Houben RM, et al. High symptom improvement and local tumor control using stereotactic radiotherapy when given early after diagnosis of meningioma: a multicentre study. Strahlenther Onkol 2012;188:887-893.
  36. Glass EN, Kapatkin A, Vite C, et al. A modified bilateral transfrontal sinus approach to the canine frontal lobe and olfactory bulb: Surgical technique and five cases. J Am Hosp Assoc 2000;36:43-50.
  37. Kostolich M, Dulisch ML. Surgical approach to the canine olfactory bulb for meningioma removal. Vet Surg 1987;16:273-277.
  38. Heidner GL, Kornegay JN, Page RL, et al. Analysis of survival in a retrospective study of 86 dogs with brain tumors. J Vet Intern Med 1991;5:219-226.
  39. Norman A, Ingram M, Skillen RG, et al. X-ray phototherapy for canine brain masses. Radiat Oncol Investig 1997;5:8-14.
  40. Yoshikawa HY, Mayer MN. External beam radiation therapy for canine intracranial meningioma. Can Vet J 2009;50:97-100.
  41. Greco JJ, Aiken SA, Berg JM, et al. Evaluation of intracranial meningioma resection with a surgical aspirator in dogs: 17 cases (1996?2004). J Am Vet Med Assoc 2006;229:394-400.
  42. Klopp LS, Rao S. Endoscopic-assisted intracranial tumour removal in dogs and cats: long-term outcome of 39 cases. J Vet Intern Med 2009;23:108-115.
  43. Sahgal A, Bauman GS. Fractionated radiotherapy. In: Bernstein M, Berger MS editors. Neuro-oncology : the essential. 3rd Thieme, New York: 181-191.
  44. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z, Kolesnick R. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003 May 16;300(5622):1155-9.
  45. El Kaffas A, Tran W, Czarnota GJ. Vascular strategies for enhancing tumour response to radiation therapy. Technol Cancer Res Treat. 2012 Oct;11(5):421-32.
  46. Uriarte A, Moissonnier P, Thibaud JL, et al. Surgical treatment and radiation therapy of frontal lobe meningiomas in 7 dogs. Can Vet J 2011;52:748-752.

[M Dolera, L Malfassi, N Carrara, S Finesso, S Marcarini, G Mazza, S Pavesi, M Sala and G Urso. (2017); STEREOTACTIC VOLUME MODULATED ARC RADIOTHERAPY PROTOCOL FOR CANINE INTRACRANIAL MENINGIOMA. Int. J. of Adv. Res. 5 (Sep). 374-390] (ISSN 2320-5407). www.journalijar.com

Mario Dolera
La Cittadina Fondazione Studi e Ricerche Veterinarie

DOI:

Article DOI: 10.21474/IJAR01/5339      
DOI URL: http://dx.doi.org/10.21474/IJAR01/5339

Download Full Paper

Download PDF No. of Downloads: 12 | No. of Views: 86